The delta endotoxins produced by Bacillus thuringiensis are each specific for insects from within one of at least three orders (3, 15) , although there are a few cases of toxicity for insects from two orders (13, 37) . Most of these toxins contain a highly conserved hydrophobic region near the amino end which is believed to be important for toxicity (15, 36) . As shown for the CryIIIA toxin (20) , this region consists of seven amphipathic helices arranged in a circle, with one, helix 5, in the center. A very similar structure has been reported recently for the CryIAa toxin (13b) . These toxins insert into the membrane of larval midgut cells following binding to specific receptors (14) . Somehow, ion-conducting channels are formed (26) (27) (28) , which eventually leads to colloid osmotic lysis of the cells (18) . Little is known about the structure of this channel, i.e., how many toxin molecules or helices from each toxin interact to form the channel. There may even be interactions between the toxin molecule(s) and larval midgut membrane proteins.
Previously, we had mutagenized regions of the cryIAc gene encoding residues within two of these helices, helix 2 and helix 5 (36) . Only mutations in the latter helix, which is the central one in the arrangement of the seven helices (20) , resulted in no or low toxicity for the three test insects, Manduca sexta, Heliothis virescens, and Trichoplusia ni. Many of the mutant toxins with no detectable activity have now been shown to be readily digested by trypsin or insect gut extract (13a) , and this instability could account for the lack of toxicity. Stable mutant toxins competed well with wild-type CryIAc toxin for binding to larval midgut vesicles, so the low toxicity must be due to either the lack of insertion into the membrane or the inability to form an ion channel.
A second region of these toxins which includes residues ca. 330 to 600, the so-called hypervariable region, is involved in specificity (12) . These residues make up domains II and III of the CryIA and CryIIIA toxins and are arranged primarily in beta sheets. Exchanges between complementary restriction fragments within these regions of the cryIAa and cryIAc genes have helped to define specificity domains for the insects mentioned above and for Bombyx mori (11, 19) . On the basis of toxicity assays of these hybrid toxins, it appeared that the H. virescens specificity domain was between residues 332 and 607, and that for T. ni and B. mori was between residues 332 and 447 (11, 25) . There was a correlation between the toxicity of hybrid toxins for B. mori and the binding to midgut vesicles from these larvae (19) . A critical region for M. sexta was thought to be amino acids 429 to 447 (25) , but exchanges or point mutations in the region encoding these residues resulted in the formation of unstable toxins (1, 10) .
We have extended our approach of using 30-nucleotide mutagenic oligonucleotides to obtain random mutations of 10-amino-acid sequences within the CryIAc toxin (36) . We chose to mutagenize a region encoding another one of the amphipathic helices (helix 6) thought to be involved in toxicity and a portion of a loop within the hypervariable region (in domain III) which is unique to the CryIAc toxin. Mutations within helix 6, many of which should have perturbed the amphipathic structure, had little or no effect on toxicity. Alterations of certain residues within the loop region, however, had selective effects on toxicity and on the binding of these mutant toxins to specific larval membrane proteins.
MATERIALS AND METHODS
Cell growth. Phage M13 clones were propagated in Escherichia coli JM101, and other clones were propagated in E. coli DH5␣. Both were grown in LB medium (23) , and where needed, ampicillin was added to 30 g ml Ϫ1 and erythromycin was added to 130 g ml
Ϫ1
. The acrystalliferous, plasmid-cured derivative of B. thuringiensis subsp. kurstaki HD1, strain CryB, (29) or a similar derivative of B. thuringiensis subsp. israelensis (i.e., 4Q7; Bacillus Genetic Stock Center) was grown at 30ЊC on a rotary shaker in G-Tris medium (4) with or without 25 g of erythromycin ml Ϫ1 . Mutagenesis and subcloning. A 2.1-kb HincII-BclI fragment of the cryIAc gene in M13mp19 was mutagenized as described previously (36) . Mutagenic oligonucleotides encoding residues 206 to 215 within helix 6 and residues 500 to 509 within the hypervariable region were used to generate random mutations in each of these regions. Double-stranded DNA was propagated in E. coli JM101, and clones were picked at random for the sequencing of 150 to 200 nucleotides. In each case, about 30% contained nucleotide changes, and those with one or two amino acid substitutions were screened for altered toxicity as described below.
All promising mutations were then subcloned into the wild-type cryIAc gene present as a 7.6-kb SphI-SalI fragment in the shuttle vector pHT3101 (2) . For the helix 6 region, the 2.1-kb SphI-XhoI fragment from the M13 double-stranded DNA clone was subcloned into the cryIAc clone with the 1.8-kb SphI-XhoI fragment removed (Fig. 1) . Following ligation and transformation of E. coli DH5␣ (23), plasmids from transformants on LB agar plus 30 g of ampicillin ml Ϫ1 were screened for the presence of the smaller SphI-XhoI fragment. For the region encoding amino acids 500 to 509, the 0.5-kb SacI-XhoI fragment from the double-stranded M13 clone was purified from low-melting-point agarose by use of GELase (Epicentre Technologies). A three-to fivefold molar excess of this fragment was mixed with a derivative of the cryIAc clone in pHT3101 (extra SacI site deleted [ Fig. 1] ) which had been digested with the same restriction enzymes and then gel purified. The mixture was incubated at 40ЊC for 5 min and, following ligation, transformed into E. coli DH5␣ as described above. Double-stranded sequencing (ca. 250 bases) was done on all of the subcloned regions (at least two independent isolates for each mutant) within the intact gene in pHT3101 to confirm the initial sequences.
The pHT3101-cryIAc plasmids containing mutated regions were electroporated (Bio-Rad Gene Pulser; 1.75 kV, 400 ⍀, 25 F) into B. thuringiensis CryB grown at 30ЊC in 30 ml of LB medium until a reading at 660 nm of 200 Klett units was reached. The cells were centrifuged at 8,000 rpm for 8 min in a Sorvall RC2 rotor, washed once with 10 ml of cold 1 mM HEPES (N-2-hydroxyethylpiperazine-NЈ-2-ethanesulfonic acid; pH 7.0) and once with 10 ml of cold 10% glycerol, and finally suspended in less than 0.5 ml of 10% glycerol. Eighty microliters of this suspension was added to each 0.2-cm cuvette plus 0.5 to 3.0 g of the plasmids purified by the alkaline miniprep procedure (23) and dissolved in 10% glycerol. Following electroporation, the cells were diluted into 1 ml of SOC medium (23) and incubated in a shaker at 30ЊC for 2 h. Portions were plated on G-Tris agar containing 25 g of erythromycin ml Ϫ1 , and the plates were incubated at 30ЊC for 20 to 24 h. Resistant clones were screened for the presence of the appropriate plasmid, and those producing inclusions were grown on the same medium for inclusion purification.
Toxin purification and bioassays. E. coli JM101 at 1 ϫ 10 8 to 2 ϫ 10 8 cells per ml in LB medium was infected with the M13 clones at a multiplicity of infection of 10. Isopropyl-␤-D-thiogalactopyranoside (IPTG) was added to 1 mM, and the cultures were incubated on a rotary shaker at 37ЊC for 3 to 4 h. The cells were centrifuged at 8,000 rpm for 10 min and concentrated 5-to 10-fold in deionized water, and 0.1-ml volumes of various dilutions were spread on the surface of bioassay cups. Second-to third-instar larvae of M. sexta, T. ni, and H. virescens were added to the appropriate diet cup, and the cups were incubated for 7 days. in Table 2 . Those mutants with LC 50 values at least twice as high are indicated with ''L'' in Table 2 , and these were the ones analyzed further (see Table 3 ). Mutants in residues 206 to 215 were assayed on all three insects, whereas those in residues 500 to 509 were assayed only on M. sexta and H. virescens. All of the clones with higher LC 50 values which had single amino acid substitutions were grown as described above, and the cells were harvested in a Sorvall centrifuge and washed twice with 0.03 M Na 2 CO 3 (pH 9.5). The cells were suspended to one-fifth the original volume in this buffer and sonicated twice for 40 s each time by use of a microtip on a Branson 200 sonicator. ␤-Mercaptoethanol was added to 2%, the pH was adjusted to 9.5, and intact cells and debris were removed by centrifugation for 2 min in an Eppendorf Microfuge. The supernatants were dialyzed against 1,000 volumes of 0.03 M NaHCO 3 for 14 h at 4ЊC. The protein concentration was determined with the bicinchoninic acid reagent (Pierce Chemical) and tolylsulfonyl phenylalanyl chloromethyl ketone (TPCK)-trypsin was added to a ratio of 1:25 (trypsin/extract protein). After 1 h at 37ЊC, the same amount of trypsin was added, and incubation was continued for an additional hour. The digested protoxin was dialyzed in Spectr/Por MWCO 50,000 dialysis tubing (50-kDa cutoff; Spectrum) at 4ЊC for 14 h against 1,000 volumes of 50 mM Tris-150 mM NaCl (pH 7.5; TBS). The toxin concentrations were determined in immunoblots as described below.
Inclusions containing recombinant protoxins were prepared from G-Tris agar plus erythromycin plates following incubation at 30ЊC for 48 h. The plates were placed in a refrigerator for 1 h, and then spores plus inclusions were scraped from the surface in 1 M KCl-5 mM EDTA (pH 8.0). The suspensions were centrifuged at 8,000 ϫ g for 10 min, and the pellets were suspended in 1 to 3 ml of deionized water and heated at 60ЊC for 2 min to inactivate residual proteases. Following centrifugation, the pellets were washed twice with deionized water, suspended in 1 to 2 ml of water, sonicated for 5 s, and then layered on top of Renografin (E. R. Squibb) gradients in 30-ml Corex tubes. The stock solution of 76% Renografin was diluted in water to provide a discontinuous gradient of 3 ml each of 50%, 45%, and 38%. The tubes were centrifuged in a Sorvall HB4 swinging-bucket rotor at 8,000 rpm for 1 h. The spores pelleted and the band of inclusions just below the debris were removed with a Pasteur pipette. The Renografin was diluted at least 10-fold, and the inclusions were collected by centrifugation at 8,000 rpm for 20 min. A sample of the pellet was inspected in the phase-contrast microscope for purity, and if necessary, the Renografin gradient centrifugation was repeated. The final pellet was dried in a Savant Speed Vac and stored at Ϫ80ЊC.
Protoxin was solubilized by suspending the inclusions in 0.03 M Na 2 CO 3 -2% ␤-mercaptoethanol (pH 9.6; usually with a 2-to 3-s sonication). The suspension was incubated at 37ЊC for 20 min and centrifuged in an Eppendorf Microfuge for 5 min. The extraction was repeated, and the supernatants were pooled and dialyzed against 1,000 volumes of 0.03 M NaHCO 3 for 14 h at 4ЊC. The protein concentration was determined with the bicinchoninic acid reagent (Pierce Chemical), and digestion with TPCK-trypsin and dialysis were done as described above.
Toxin purity was checked by electrophoresis in sodium dodecyl sulfate (SDS)-10% polyacrylamide gel electrophoresis (10% PAGE) and staining with Coomassie blue. Samples were also transferred to polyvinylidene difluoride membranes (Immobilon P; Millipore) for immunoblotting with rabbit anti-CryIAc antibody plus a second anti-rabbit antibody-alkaline phosphatase conjugate (see Fig. 4 ). These stained immunoblots were scanned and quantitated in a Molecular Dynamics densitometer with various amounts of CryIAc toxin purified from B. thuringiensis subsp. kurstaki HD73 as standards.
Toxin binding. For assays of the binding of toxins to larval midgut proteins, midguts were dissected from fourth-to fifth-instar larvae of M. sexta and H. virescens. Vesicles prepared as described by Wolfersberger et al. (35) were stored at Ϫ80ЊC and suspended in 0.32 M sucrose to measure protein concentrations. Twenty micrograms of vesicle protein was solubilized in 50 mM Tris-40 mM dithioerythritol-10% glycerol-1% SDS-0.02% bromophenol blue (pH 6.8) and subjected to SDS-10% PAGE. Following transfer to a polyvinylidene difluoride membrane, the filters were washed twice with 50 mM Tris-150 mM NaCl-0.5% Tween 20 (pH 7.5; TBS-Tween) and blocked with nonfat dry milk. The filters were then incubated with 2 to 6 g of toxin in 5 ml of TBS-Tween-0.1% bovine serum albumin for 90 min at room temperature, washed three times with TBSTween, and incubated with the CryIAc antibody in TBS-5% nonfat dry milk for 1 h. The second antibody was added, and the filters were washed as described elsewhere (21) . Blots of the binding to H. virescens vesicle proteins were quantitated in a Molecular Dynamics densitometer.
RNA isolation and hybridization. Total RNA was isolated from 75 ml of sporulating cells (when Ͻ50% and Ͼ80% contained phase white endospores; 2-h interval) as described elsewhere (5) . Two and 10 g of RNA were diluted into formamide denaturation buffer and collected on a nitrocellulose membrane in a Millipore slot blot apparatus. Following baking at 80ЊC for 2 h in a vacuum oven, the filter was hybridized to a gel-purified 
RESULTS
Mutations within an amphipathic helix did not result in altered toxicity. The mutations generated in helix 6 are displayed as a helical wheel (Fig. 2) . The M13 clones were tested for toxicity against three insects, and in no case were there substantial (i.e., greater-than-twofold) changes in LC 50 values. Four of the mutant regions encoding the Y-to-D mutation at position 211 (Y211D), W210C, Y211C, and G214E were subcloned into a wild-type cryIAc gene in the shuttle vector pHT3101 (2). These inclusions or the toxins prepared from them were also as toxic as the wild type (LC 50 values of 1 to 2 ng cm Ϫ2 ). For one mutation, Y211D, less protoxin was recovered from a mixture of spores and inclusions from the transformant (even at 25ЊC) than was found for the wild type or other mutant clones (Fig. 3A) . The steady-state amount of cryIAc mRNA in this mutant was about the same as that in the wild type (Fig. 3B) , so the defect is probably in the instability of this protoxin in sporulating cells. Despite this instability, stable toxin was present after digestion with trypsin, and this toxin was as active as the wild-type toxin. The plasmid containing the Y211D mutation was isolated from the transformant and reintroduced into this strain by electroporation. The same low accumulation of protoxin was found in all of the transformants, indicating that a mutation in the host strain did not account for the defect. The subcloning of the region containing the Y211D mutation was done two additional times with the same result.
Mutations within a unique portion of the hypervariable region resulted in a selective loss of toxicity. Amino acids 500 to 509 in the CryIAc toxin are part of the hypervariable region which is unique to this toxin (Table 1 ) and are present in a prominent loop within domain III (20) . As summarized in Table 2 , only changes of Ser-503 and Ser-504 resulted in lower toxicity. All of these mutant toxins were stable to trypsin digestion (Fig. 4) , so toxins prepared from the M13 clones were bioassayed more extensively (Table 3 ). There was a much greater loss of toxicity for M. sexta than for H. virescens, and these results were confirmed with toxins prepared from inclusions from B. thuringiensis transformants.
The lower toxicity for M. sexta correlated with the substantial decrease in binding of these mutant toxins to the single CryIAc larval midgut vesicle-binding protein (Fig. 5A) . Binding of the FIG. 4 . Stable toxin is produced after digestion with trypsin of M13 extracts containing the 219-18 (S503I) and 219-7 (S504I) mutant toxins. Crude dialyzed extracts, each containing about 1 g of the mutant or wild-type (wt) ca. 78-kDa protoxins (36) , were digested with trypsin, electrophoresed in an SDS-10% polyacrylamide gel, and transferred to an Immobilon P membrane for immunoblotting. Lanes labeled IAc are 0.3 and 1.0 g of toxin prepared from B. thuringiensis subsp. kurstaki HD73. The major bands (all at ca. 65 kDa) were quantitated in a Molecular Dynamics densitometer. Table 3 for LC 50 values of extracted toxins.)
CryIAc toxin to vesicle proteins from H. virescens larvae was more complex (Fig. 5B) . At 0.5 g of toxin, there was binding to only two high-molecular-weight proteins, as reported previously (21) . At 1 or 3 g of toxin, there was binding to three or four additional bands with lower molecular weights. As discussed later, these are more likely to be less-abundant binding proteins or those with lower affinities for the CryIAc toxin than degradation products of the higher-molecular-weight binding proteins. There was a substantial decrease in the binding of both mutant toxins to the two high-molecular-weight proteins, somewhat less binding to the lower-molecular-weight bands, and a relatively smaller loss of binding to the band designated with an arrow (Fig. 5B) . Because of the more-extensive background in the blots in Fig. 5B , the bands were quantitated in a densitometer. Of the three larger bands, the values for the two mutant toxins (219-7 [S504I] and 219-18 [S503I]) were 10 to 20%, 5 to 10%, and 60 to 80% (larger to smaller) of the values in the M13-wt lane.
DISCUSSION
One of the segments mutagenized is within a highly conserved region of most toxins which consists of amphipathic helices. On the basis of the published structure of the CryIIIA toxin (20) and the report of a very similar structure for the CryIAa toxin (13b), the mutagenesis was in a 10-amino-acid stretch within one of the peripheral helices, helix 6. None of these mutants had substantially lower toxicity for the three test insects, despite some changes which should have altered the amphipathic properties of this helix, i.e., R209A, R209P, T213A, W210L, V218N, and Y211N, -R, or -D. In addition, several of the substitutions resulted in changes in residue size (W210S and G214E or -V), and yet none of these perturbations affected toxicity. In one case (Y211D), there was reduced stability, i.e., less protoxin accumulation, although stable, active toxin was produced following digestion with trypsin. The instability is apparently due to the susceptibility of this particular protoxin to B. thuringiensis proteases. Since the specific toxicity of the Y211D toxin was about the same as that of the wild type, altered protoxin stability does not necessarily mean reduced toxicity. The naturally occurring CryIAb protoxin is also unstable as a result of a deletion of 26 residues in the carboxyl half (3). It should be noted, however, that for many of the mutations within the central helix 5 which resulted in no detectable toxicity (36) , the mutant protoxins were unstable in B. thuringiensis and the toxins were very sensitive to trypsin or to the proteases present in M. sexta midgut extracts (13a). In these cases, instability could account for the lack of toxicity, as has been reported for a number of hybrid toxins (1, 10) .
We have now generated mutations within three of the seven helices which constitute domain I of these toxins, and only those within the central helix 5 have resulted in a substantial number with no or low toxicity for three test insects (36) . The stable mutant toxins do compete well for binding, so they must either insert poorly into the membrane or not form functional ion channels. It appears on the basis of mutations within 10-amino-acid stretches of helices 2 and 6 that these helices are either not critical for the formation of the ion channel or have functions which allow considerable flexibility in their structures. Experiments with a synthetic peptide from helix 5 indicated that this helix, presumably in an aggregated state, was sufficient for pore formation (8, 9) . If such studies are a valid model for the action of this toxin in vivo, then the other amphipathic helices may have secondary roles in toxin insertion or in stabilizing the ion channel.
The region encoding residues 500 to 509 of the CryIAc toxin was selected for mutagenesis because it is unique to this toxin and is within a prominent loop in the so-called hypervariable region (12) . Most sequence differences among the closely related CryIA toxins, each with a unique specificity profile for lepidoptera, are within this region (15) . In addition, hybrids between the cryIAa and cryIAc genes delineated fairly broad portions of the hypervariable region which were important for toxicity for specific insects (10, 11, 25) . Residues 429 to 447 were found to be particularly critical for M. sexta toxicity (25) , although the lower toxicity of these hybrids is apparently due to toxin instability (1, 10) . This sequence, which is conserved among a number of CryI toxins, is also within a prominent loop. These loops are in close proximity, so they are attractive candidates for participating in the formation of a toxin binding domain. Several toxins display saturable binding to membrane vesicles prepared from larval midguts, and in many of these cases, there are correlations between the susceptibility of an insect to a particular toxin and either the binding constant or the number of binding sites (14, 19, 31, 32) . There is also decreased binding of the CryIA toxins to larval midgut membranes prepared from insects selected for resistance to these toxins (6, 33) . There are exceptions to these correlations (32, 34) , but in general, the results support a two-step model of binding to a receptor and then insertion into the membrane. Consistent with a two-step process is the evidence for both reversible and irreversible binding of certain toxins to B. mori vesicles (16) . There was high-affinity binding of the CryIAa and CryIAb toxins presumably to the same or to overlapping receptor sites since they competed, but the binding of the latter was largely reversible. The CryIAb toxin is not very effective on these larvae, whereas the irreversibly bound CryIAa toxin is very active, indicating that it is the second step which is more critical for specificity.
The importance of the initial binding was established by the correlation between the decreased binding of the S503I, S504I, and S503G mutant toxins to specific membrane proteins and lower toxicity. Since the amino acid sequence between residues 500 and 509 is unique to the CryIAc toxin (Table 1) , the loop containing these residues probably contributes to the initial, specific reversible binding. A total of 21 mutant toxins were analyzed, and only changes of the contiguous serines resulted in lower toxicity and decreased binding, indicating that hydrogen bonding of these residues to the receptor is likely to be involved in the specific interaction.
The CryIAc toxin is more active on H. virescens than M. sexta (15) , yet these serine mutations resulted in a more-extensive loss of toxicity for the latter (Table 3 ). There is a single CryIAc-binding protein in M. sexta vesicles which has been identified as an aminopeptidase (17, 24) . This enzyme and perhaps a phosphatase may function to mobilize toxin at the membrane as well as to enhance toxin insertion (24) . A separate CryIAb-binding protein (30) may function in the same way.
In contrast, two CryIAc-binding proteins of 120 and 140 kDa were reported in H. virescens (7, 21, 22) , and there may be an additional three or four more with lower molecular masses (Fig. 5B) . The latter were detected only at relatively high toxin concentrations, so they are probably either less abundant or have a lower affinity for the CryIAc toxin. The presence of these bands could be due to degradation of the higher-molecular-weight binding proteins during extraction, but the pattern was unchanged by varying the extraction conditions or by incubating the vesicle extract at 27ЊC for 3 h prior to electrophoresis. In all cases, only a single high-molecular-weight CryIAb-binding protein was found, as reported by others (21, 22) . In addition, there was no detectable degradation of the single M. sexta CryIAc-binding protein because of the mixing of these vesicles with H. virescens vesicles (ratio of 5:1) prior to extraction.
Each of these H. virescens binding proteins may be recognized with different affinities by a different domain in this toxin, a possibility consistent with the very broad toxicity region (residues 332 to 607) as defined in hybrid toxins (10, 25) . The number of CryIAc binding sites in H. virescens vesicles is two to three times that of the CryIAb sites, correlating with the greater susceptibility of this insect to the former toxin (31) . Competition binding experiments indicated heterogeneity among these sites (31) , as also noted here (Fig. 5B) . The fact that modification of any small region between residues 332 and 607 resulted in only a ca. fivefold decrease in toxicity (Table 3 ) (25) and the different extents of loss of binding to the multiple H. virescens vesicle proteins by the S503I and S504I mutant toxins (Fig. 5B) are consistent with multiple CryIAc binding domains for H. virescens. It should be possible to establish a better definition of toxin binding domains, including those required for specific membrane insertion, by extending the analysis of point mutations in these critical regions.
